Comparison of the in vitro activities of ceftazidime-avibactam and ceftolozane-tazobactam against clinical isolates of Pseudomonas aeruginosa: ATLAS global surveillance programme 2020–2024

Journal of Global Antimicrobial Resistance · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles